These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8446268)

  • 1. Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):303-8. PubMed ID: 8446268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):309-13. PubMed ID: 8446269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis fluid temperature and vasoactive substances during routine hemodialysis.
    Hegbrant J; Mãrtensson L; Ekman R; Nielsen AL; Thysell H
    ASAIO J; 1994; 40(3):M678-82. PubMed ID: 8555600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    Clin Nephrol; 1994 Feb; 41(2):106-12. PubMed ID: 8004826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment.
    Hegbrant J; Thysell H; Ekman R
    Scand J Urol Nephrol; 1992; 26(2):169-76. PubMed ID: 1378231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis.
    Hegbrant J; Thysell H; Ekman R
    Int J Artif Organs; 1991 Jul; 14(7):411-6. PubMed ID: 1889894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
    Heintz B; Reiners K; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis.
    Odar-Cederlöf I; Theodorsson E; Eriksson CG; Hamberger B; Tidgren B; Kjellstrand CM
    Int J Artif Organs; 1993 Sep; 16(9):662-9. PubMed ID: 8294159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and vasoactive peptides in hemodialysis patients.
    Hegbrant J; Ekman R; Thysell H
    Blood Purif; 1998; 16(3):135-9. PubMed ID: 9681155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
    Heintz B; Königs F; Dakshinamurty KV; Kierdorf H; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H
    Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma 2-MSH increases during graded exercise in healthy subjects: comparison with plasma catecholamines, neuropeptides, aldosterone and renin activity.
    Valdemarsson S; Andersson D; Bengtsson A; Bogren M; Edvinsson L; Ekman R
    Clin Physiol; 1990 Jul; 10(4):321-7. PubMed ID: 2203597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN; Vaziri ND; Pandian MR; Kaupke J
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH.
    Bertagna X; Donnadieu M; Idatte JM; Girard F
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1179-86. PubMed ID: 201658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension.
    Noris M; Todeschini M; Casiraghi F; Roccatello D; Martina G; Minetti L; Imberti B; Gaspari F; Atti M; Remuzzi G
    Am J Kidney Dis; 1998 Jul; 32(1):115-24. PubMed ID: 9669432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin in end-stage renal disease: relationship to salt, catecholamines and renin activity.
    Papadoliopoulou-Diamandopoulou N; Papagalanis N; Gavras I; Gavras H
    Clin Exp Hypertens A; 1987; 9(7):1197-208. PubMed ID: 3304733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.